These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 38761253)
1. From metabolomics to proteomics: understanding the role of dopa decarboxylase in Parkinson's disease. Scientific commentary on: "Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson's disease". Shebl N; Salama M Acta Neuropathol; 2024 May; 147(1):88. PubMed ID: 38761253 [No Abstract] [Full Text] [Related]
2. Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson's disease. Rutledge J; Lehallier B; Zarifkar P; Losada PM; Shahid-Besanti M; Western D; Gorijala P; Ryman S; Yutsis M; Deutsch GK; Mormino E; Trelle A; Wagner AD; Kerchner GA; Tian L; Cruchaga C; Henderson VW; Montine TJ; Borghammer P; Wyss-Coray T; Poston KL Acta Neuropathol; 2024 Mar; 147(1):52. PubMed ID: 38467937 [TBL] [Abstract][Full Text] [Related]
3. DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson's disease. Appleton E; Khosousi S; Ta M; Nalls M; Singleton AB; Sturchio A; Markaki I; Paslawski W; Iwaki H; Svenningsson P Transl Neurodegener; 2024 Jun; 13(1):31. PubMed ID: 38863007 [No Abstract] [Full Text] [Related]
13. Integrated metabolomics and proteomics analysis of plasma lipid metabolism in Parkinson's disease. Gątarek P; Kałużna-Czaplińska J Expert Rev Proteomics; 2024; 21(1-3):13-25. PubMed ID: 38346207 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal Fluid Metabolome in Parkinson's Disease and Multiple System Atrophy. Kwon DH; Hwang JS; Kim SG; Jang YE; Shin TH; Lee G Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163800 [TBL] [Abstract][Full Text] [Related]